Anthem Biosciences Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2025.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has submitted its financial results for the quarter and half year ended September 30, 2025 to the stock exchange. This is a routine compliance filing notifying the market that the results have been filed. The announcement itself does not contain any actual revenue, profit, or margin figures. Investors would need to refer to the detailed financial results document to assess the company's performance.
No direct stock price impact from this filing alone, as it is only a submission notification. The real market reaction will depend on the actual numbers in the detailed results versus expectations.